Ignite Creation Date:
2024-05-06 @ 8:14 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06302621
Status:
RECRUITING
Last Update Posted:
2024-04-26
First Post:
2022-08-10
Brief Title:
Pemigatinib Afatinib in Advanced Refractory Solid Tumors
Sponsor:
Organization:
Massachusetts General Hospital